Management of Rheumatoid Arthritis: Consensus Recommendations From the Turkish League Against Rheumatism

Şebnem ATAMAN, (Ankara Üniversitesi, Tıp Fakültesi, Fiziksel Tıp ve Rehabilitasyon Anabilim Dalı, Romatoloji Bilim Dalı, Ankara, Türkiye)
Pınar BORMAN, (Ankara Eğitim ve Araştırma Hastanesi, Fiziksel Tıp ve Rehabilitasyon Kliniği, Ankara, Türkiye)
Deniz EVCİK, (Ankara Üniversitesi, Haymana Meslek Yüksekokulu, Fizik Terapi ve Rehabilitasyon Anabilim Dalı, Ankara, Türkiye)
Ece AYDOĞ, (Yeditepe Üniversitesi, Tıp Fakültesi, Fiziksel Tıp ve Rehabilitasyon Anabilim Dalı, İstanbul, Türkiye)
Fikriye Figen AYHAN, (Ankara Eğitim ve Araştırma Hastanesi, Fiziksel Tıp ve Rehabilitasyon Kliniği, Ankara, Türkiye)
Derya YILDIZLAR, (Ankara Üniversitesi, Tıp Fakültesi, Fizik Tedavi ve Rehabilitasyon Anabilim Dalı, Ankara, Türkiye)
Hatice BODUR, (Ankara Numune Eğitim ve Araştırma Hastanesi, Fiziksel Tıp ve Rehabilitasyon Kliniği, Ankara, Türkiye)
Zuhal ALTAY, (İnönü Üniversitesi, Tıp Fakültesi, Fiziksel Tıp ve Rehabilitasyon Anabilim Dalı, Malatya, Türkiye)
Murat BİRTANE, (Trakya Üniversitesi, Tıp Fakültesi, Fiziksel Tıp ve Rehabilitasyon Anabilim Dalı, Edirne, Türkiye)
Bülent BÜTÜN, (Akdeniz Üniversitesi, Tıp Fakültesi, Fiziksel Tıp ve Rehabilitasyon Anabilim Dalı, Antalya, Türkiye)
Mehmet Tuncay DURUÖZ,
Hatice Rana ERDEM,
Zafer GÜNENDİ,
Rezzan GÜNAYDIN,
Gülcan GÜRER,
Cahit KAÇAR,
Ece KAPTANOĞLU,
Taciser KAYA,
Neşe ÖLMEZ,
Nurdan PAKER,
Aylin REZVANİ,
BİRKAN SONEL TUR,
Mahmut YENER,
Salih ÖZGÖÇMEN,
Turkish Journal of Rheumatology(.)Archives of Rheumatology
4 1
Yıl: 2011 Cilt: 26 Sayı: 4 Sayfa Aralığı: 273 - 294 Metin Dili: Türkçe İndeks Tarihi: 29-07-2022

Management of Rheumatoid Arthritis: Consensus Recommendations From the Turkish League Against Rheumatism

Öz:
Amaç: Türkiye Romatizma Araştırma ve Savaş Derneği (TRASD) romatoid artrit tedavisindeki yeni gelişmeleri ve ülkemizin ekonomik koşullarını göz önünde bulundurarak, RA tedavisine yönelik ulusal tedavi önerileri geliştirmeyi amaçlamıştır ve bu amaçla, fikirlerini almak için ulusal uzmanlara danışmıştır.Gereç ve yöntemler: Bu alanda deneyimli olan sekiz romatolog ve 15 fizik tedavi uzmanı TRASD'nin RA tedavisi önerilerinin geliştirilmesine katkıda bulunmuştur. Uzmanlar kurulu, EULAR 2010'da yer alan RA'nın sentetik ve biyolojik hastalık modifiye edici antiromatizmal ajanlarla (DMARD'ler) tedavi önerilerini baz alarak, uzman görüşlerinin de yer aldığı bir "Türkiye RA Tedavi Önerileri" oluşturulmasını planlamıştır. Toplantının ardından, Medline ve Cochrane, Embase ve Türk Tıp Dizini veritabanlarında farmakolojik tedavi önerileri için 2009 ile 2010 yılları arasını, non-farmakolojik tedavi için ise 2007 ile 2010 yılları arasını kapsayan aramalar gerçekleştirilerek sistematik bir literatür taraması yürütülmüştür. Bu işlem EULAR 2010 önerilerine dahil edilen çalışmalara ilave olarak yapılmıştır. Tüm makaleler incelenmiştir, içerikler özetlenmiştir, kanıt seviyeleri belirlemiştir ve Delphi işlemi başlatılmıştır.Bulgular: Beş ana prensip ve bir non-farmakolojik tedavi yöntemiyle birlikte 16 genel öneri sıralanmıştır. Tüm öneriler konusunda uzlaşıya varılmıştır ve önerilerin kuvvet seviyeleri oylanmıştır.Sonuç: Türkiye'deki RA tedavisine yönelik öneriler oluşturulmuştur. Bu ulusal önerilerin fizik tedavi ve rehabilitasyon uzmanlarına (fizyatri uzmanlarına) romatologlara ve aile hekimlerine yönelik bir kılavuz olarak işlev görmesi amaçlanmıştır ve önerilerin düzenli şekilde güncellenmesi gerekmektedir.
Anahtar Kelime:

Konular: Romatoloji

Romatoid Artritin Tedavisi: Türkiye Romatizma Araştırma ve Savaş Derneği Uzlaşı Önerileri

Öz:
Objectives: Taking new developments in the management of rheumatoid arthritis (RA) and the economic conditions of our country into account, the Turkish League Against Rheumatism (TLAR) aimed to develop national treatment recommendations for the management of RA; thus, they consulted with national experts for their opinions. Materials and methods: Eight rheumatologists and 15 physiatrists experienced in the field contributed to the development of the TLAR recommendations for the management of RA. The expert committee planned to develope "Recommendations for the Management of RA in Turkey" based on EULAR 2010 recommendations for the management of RA with synthetic and biological disease-modifying antirheumatic drugs (DMARDs) in light of expert opinions. Following the meeting, a systematic literature review was performed by searching the Medline and Cochrane, Embase, and Turkish Medical Index databases between 2009 and 2010 for pharmacological treatment recommendations and between 2007 and 2010 for non-pharmacological treatment recommendations. This was done in addition to the studies included in the EULAR 2010 recommendations. All articles were examined, their contents were summarized, their levels of evidence were determined, and the Delphi process was initiated. Results: Sixteen general recommendations were listed along with five main principles and one non-pharmacological treatment method. A consensus was reached for all recommendations, and their strength levels were voted upon. Conclusion: Recommendations were formed for the management of RA in Turkey. These national recommendations are intended to guide physical medicine and rehabilitation specialists (physiatrists), rheumatologists, and family physicians and should be regularly updated.
Anahtar Kelime:

Konular: Romatoloji
Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • Smolen JS, Landewé R, Breedveld FC, Dougados M, Emery P, Gaujoux-Viala C, et al . EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs . Ann Rheum Dis 2010;69:964-75 .
  • Smolen JS, Aletaha D, Bijlsma JW, Breedveld FC, Boumpas D, Burmester G, et al . Treating rheumatoid arthritis to target: recommendations of an international task force . Ann Rheum Dis 2010 ;69:631-7 .
  • Saag KG, Teng GG, Patkar NM, Anuntiyo J, Finney C, Curtis JR, et al . American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis . Arthritis Rheum 2008;59:762-84 .
  • Furst DE, Keystone EC, Fleischmann R, Mease P, Breedveld FC, Smolen JS, et al . Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2009 . Ann Rheum Dis 2010;69 Suppl 1:i2-29 .
  • Oxford Centre for Evidince Based Medicine . Levels of Evidence; March 2009 . Abailable from: http://www2 . cch .org .tw/ebm/file/CEBM-Levels-of-Evidence .pdf
  • Linstone HA, Turoff M . The Delphi Method: Techniques and Applications . Reading, Massachusetts: Adison- Wesley; 1975 .
  • Tababet Uzmanlık Tüzüğü . Resmi Gazete 18 Nisan 1973; Sayı: 14511, Tababet Uzmanlık Dalları, Yan Dalları ve Asistanlık Süreleri: Madde 5 - (Degişik: 5 Temmuz 1983 - 83/6834 K .)
  • Tıpta Uzmanlık Tüzüğü 2002 . Resmi Gazete Tarihi: 19 Haziran 2002, Sayı: 24790, Karar Sayısı: 2002/4198 .
  • Riemsma RP, Kirwan JR, Taal E, Rasker JJ . Patient education for adults with rheumatoid arthritis . Cochrane Database Syst Rev 2003;CD003688 .
  • Hammond A, Freeman K . One-year outcomes of a randomized controlled trial of an educational- behavioural joint protection programme for people with rheumatoid arthritis . Rheumatology (Oxford) 2001;40:1044-51 .
  • Masiero S, Boniolo A, Wassermann L, Machiedo H, Volante D, Punzi L . Effects of an educational-behavioral joint protection program on people with moderate to severe rheumatoid arthritis: a randomized controlled trial . Clin Rheumatol 2007;26:2043-50 .
  • Iversen MD . Arthritis patient education and team approaches to management . In: Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH, editors . Rheumatology . Philadelphia: Elsevier; 2011 . p . 427-32 .
  • van der Heide A, Jacobs JW, Bijlsma JW, Heurkens AH, van Booma-Frankfort C, van der Veen MJ, et al . The effectiveness of early treatment with "second-line" antirheumatic drugs . A randomized, controlled trial . Ann Intern Med 1996;124:699-707 .
  • Orlewska E, Ancuta I, Anic B, Codrenau C, Damjanov N, Djukic P, et al . Access to biologic treatment for rheumatoid arthritis in Central and Eastern European (CEE) countries . Med Sci Monit 2011;17:SR1-13 .
  • Suarez-Almazor ME, Belseck E, Shea B, Wells G, Tugwell P . Sulfasalazine for rheumatoid arthritis . Cochrane Database Syst Rev 2000;CD000958 .
  • Jeurissen ME, Boerbooms AM, van de Putte LB, Doesburg WH, Mulder J, Rasker JJ, et al . Methotrexate versus azathioprine in the treatment of rheumatoid arthritis . A forty-eight-week randomized, double-blind trial . Arthritis Rheum 1991;34:961-72 .
  • Strand V, Tugwell P, Bombardier C, Maetzel A, Crawford B, Dorrier C, et al . Function and health-related quality of life: results from a randomized controlled trial of leflunomide versus methotrexate or placebo in patients with active rheumatoid arthritis . Leflunomide Rheumatoid Arthritis Investigators Group . Arthritis
  • Dudler J, Möller B, Michel BA, Villiger PM . Biologics in rheumatoid arthritis-recommendations for Swiss practice . Swiss Med Wkly 2011;141:w13189 .
  • Montag K, Gingold M, Boers A, Littlejohn G . Disease- modifying anti-rheumatic drug usage, prescribing patterns and disease activity in rheumatoid arthritis patients in community-based practice . Intern Med J 2011;41:450-5 .
  • Conaghan PG, Hensor EM, Keenan AM, Morgan AW, Emery P; YEAR Consortium . Persistently moderate DAS-28 is not benign: loss of function occurs in early RA despite step-up DMARD therapy . Rheumatology (Oxford) 2010;49:1894-9 .
  • Möttönen T, Hannonen P, Leirisalo-Repo M, Nissilä M, Kautiainen H, Korpela M, et al . Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial . FIN-RACo trial group . Lancet 1999;353:1568-73 .
  • Grigor C, Capell H, Stirling A, McMahon AD, Lock P, Vallance R, et al . Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial . Lancet 2004;364:263-9 .
  • Allaart CF, Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Breedveld FC, Dijkmans BA; FARR study group . Aiming at low disease activity in rheumatoid arthritis with initial combination therapy or initial monotherapy strategies: the BeSt study . Clin Exp Rheumatol 2006;24:S-77-82 .
  • Verstappen SM, Jacobs JW, van der Veen MJ, Heurkens AH, Schenk Y, ter Borg EJ, et al . Intensive treatment with methotrexate in early rheumatoid arthritis: aiming for remission . Computer Assisted Management in Early Rheumatoid Arthritis (CAMERA, an open-label strategy trial) . Ann Rheum Dis 2007;66:1443-9 .
  • Mclnnes IB, Jacobs JWG, Woodburn J, Jacob M van Laar . Tratment of rheumatoid arthritis . In: Bijlsma JWJ, Burmester GR, Silva JAP, Faarvang KL, Hachulla E, Mariette X, editors . EULAR Compendium on rheumatic diseases . London: BMJ Publishing Group; 2009 . p . 81-91 .
  • Rath T, Rubbert A . Drug combinations with methotrexate to treat rheumatoid arthritis . Clin Exp Rheumatol 2010;28:S52-7 .
  • Aletaha D, Smolen JS . The rheumatoid arthritis patient in the clinic: comparing more than 1,300 consecutive DMARD courses . Rheumatology (Oxford)
  • Katchamart W, Trudeau J, Phumethum V, Bombardier C . Efficacy and toxicity of methotrexate (MTX) monotherapy versus MTX combination therapy with non-biological disease-modifying antirheumatic drugs in rheumatoid arthritis: a systematic review and meta-analysis . Ann Rheum Dis 2009;68:1105-12 .
  • Katchamart W, Trudeau J, Phumethum V, Bombardier C . Methotrexate monotherapy versus methotrexate combination therapy with non- biologic disease modifying anti-rheumatic drugs for rheumatoid arthritis . Cochrane Database Syst Rev 2010;CD008495 .
  • Krüger K . Combination therapy using methotrexate with DMARDs or biologics-current status . Z Rheumatol 2011;70:114-22 . [Abstract]
  • Rau R, Schleusser B, Herborn G, Karger T . Longterm combination therapy of refractory and destructive rheumatoid arthritis with methotrexate (MTX) and intramuscular gold or other disease modifying antirheumatic drugs compared to MTX monotherapy . J Rheumatol 1998 ;25:1485-92 .
  • Oliver AM, St .Clair EW . Rheumatoid arthritis/treatment and assesment . In: Klippel JH, editor . Primer on rheumatic diseases . Atlanta: Springer; 2008 . p . 133-41 .
  • Ma MH, Kingsley GH, Scott DL . A systematic comparison of combination DMARD therapy and tumour necrosis inhibitor therapy with methotrexate in patients with early rheumatoid arthritis . Rheumatology (Oxford) 2010;49:91-8 .
  • Chen YF, Jobanputra P, Barton P, Jowett S, Bryan S, Clark W, et al . A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness . Health Technol Assess 2006;10:iii-iv, xi-xiii, 1-229 .
  • Anderson PJ . Tumor necrosis factor inhibitors: clinical implications of their different immunogenicity profiles . Semin Arthritis Rheum 2005;34:19-22 .
  • Behrens F, Koehm M, Burkhardt H . Update 2011: leflunomide in rheumatoid arthritis-strengths and weaknesses . Curr Opin Rheumatol 2011;23:282-7 .
  • Kunkel G, W Cannon G . Leflunomide in the treatment of rheumatoid arthritis . Expert Rev Clin Immunol 2006;2:17-31 .
  • Sharp JT, Strand V, Leung H, Hurley F, Loew-Friedrich I . Treatment with leflunomide slows radiographic progression of rheumatoid arthritis: results from three randomized controlled trials of leflunomide in patients with active rheumatoid arthritis . Leflunomide Rheumatoid Arthritis Investigators Group . Arthritis Rheum 2000;43:495-505 .
  • Larsen A, Kvien TK, Schattenkirchner M, Rau R, Scott DL, Smolen JS, et al . Slowing of disease progression in rheumatoid arthritis patients during long-term treatment with leflunomide or sulfasalazine . Scand J Rheumatol 2001;30:135-42 .
  • Strand V, Tugwell P, Bombardier C, Maetzel A, Crawford B, Dorrier C, et al . Function and health-related quality of life: results from a randomized controlled trial of leflunomide versus methotrexate or placebo in patients with active rheumatoid arthritis . Leflunomide Rheumatoid Arthritis Investigators Group . Arthritis Rheum 1999;42:1870-8 .
  • Strand V, Scott DL, Emery P, Kalden JR, Smolen JS, Cannon GW, et al . Physical function and health related quality of life: analysis of 2-year data from randomized, controlled studies of leflunomide, sulfasalazine, or methotrexate in patients with active rheumatoid arthritis . J Rheumatol 2005;32:590-601 .
  • Sulfasalazine in early rheumatoid arthritis . The Australian Multicentre Clinical Trial Group . J Rheumatol 1992;19:1672-7 .
  • Hannonen P, Möttönen T, Hakola M, Oka M . Sulfasalazine in early rheumatoid arthritis . A 48-week double-blind, prospective, placebo-controlled study . Arthritis Rheum 1993;36:1501-9 .
  • Williams HJ, Ward JR, Dahl SL, Clegg DO, Willkens RF, Oglesby T, et al . A controlled trial comparing sulfasalazine, gold sodium thiomalate, and placebo in rheumatoid arthritis . Arthritis Rheum 1988;31:702-13 .
  • Rains CP, Noble S, Faulds D . Sulfasalazine . A review of its pharmacological properties and therapeutic efficacy in the treatment of rheumatoid arthritis . Drugs 1995;50:137-56 .
  • Weinblatt ME, Reda D, Henderson W, Giobbie-Hurder A, Williams D, Diani A, et al . Sulfasalazine treatment for rheumatoid arthritis: a metaanalysis of 15 randomized trials . J Rheumatol 1999;26:2123-30 .
  • Jones G, Halbert J, Crotty M, Shanahan EM, Batterham M, Ahern M . The effect of treatment on radiological progression in rheumatoid arthritis: a systematic review of randomized placebo-controlled trials . Rheumatology (Oxford) 2003;42:6-13 .
  • Aviña-Zubieta JA, Galindo-Rodriguez G, Newman S, Suarez-Almazor ME, Russell AS . Long-term effectiveness of antimalarial drugs in rheumatic diseases . Ann Rheum Dis 1998;57:582-7 .
  • Suarez-Almazor ME, Belseck E, Shea B, Homik J, Wells G, Tugwell P . Antimalarials for rheumatoid arthritis . Cochrane Database Syst Rev 2000;CD000959 .
  • Rantalaiho V, Korpela M, Laasonen L, Kautiainen H, Järvenpää S, Hannonen P, et al . Early combination disease-modifying antirheumatic drug therapy and tight disease control improve long-term radiologic outcome in patients with early rheumatoid arthritis: the 11-year results of the Finnish Rheumatoid Arthritis Combination Therapy trial . Arthritis Res Ther 2010;12:R122 .
  • Tosh JC, Wailoo AJ, Scott DL, Deighton CM . Cost- effectiveness of combination nonbiologic disease- modifying antirheumatic drug strategies in patients with early rheumatoid arthritis . J Rheumatol 2011;38:1593-600 .
  • Boers M, Verhoeven AC, Markusse HM, van de Laar MA, Westhovens R, van Denderen JC, et al . Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis . Lancet 1997;350:309-18 .
  • Hetland ML, Stengaard-Pedersen K, Junker P, Lottenburger T, Ellingsen T, Andersen LS, et al . Combination treatment with methotrexate, cyclosporine, and intraarticular betamethasone compared with methotrexate and intraarticular betamethasone in early active rheumatoid arthritis: an investigator-initiated, multicenter, randomized, double-blind, parallel- group, placebo-controlled study . Arthritis Rheum 2006;54:1401-9 .
  • Möttönen T, Hannonen P, Korpela M, Nissilä M, Kautiainen H, Ilonen J, et al . Delay to institution of therapy and induction of remission using single-drug or combination-disease-modifying antirheumatic drug therapy in early rheumatoid arthritis . Arthritis Rheum 2002;46:894-8 .
  • Dougados M, Combe B, Cantagrel A, Goupille P, Olive P, Schattenkirchner M, et al . Combination therapy in early rheumatoid arthritis: a randomised, controlled, double blind 52 week clinical trial of sulphasalazine and methotrexate compared with the single componentS . Ann Rheum Dis 1999;58:220-5 .
  • Haagsma CJ, van Riel PL, de Jong AJ, van de Putte LB . Combination of sulphasalazine and methotrexate versus the single components in early rheumatoid arthritis: a randomized, controlled, double-blind, 52 week clinical trial . Br J Rheumatol 1997;36:1082-8 .
  • Calgüneri M, Pay S, Calişkaner Z, Apraş S, Kiraz S, Ertenli I, et al . Combination therapy versus monotherapy for the treatment of patients with rheumatoid arthritis . Clin Exp Rheumatol 1999;17:699-704 .
  • Saunders SA, Capell HA, Stirling A, Vallance R, Kincaid W, McMahon AD, et al . Triple therapy in early active rheumatoid arthritis: a randomized, single-blind, controlled trial comparing step-up and parallel treatment strategies . Arthritis Rheum 2008;58:1310-7 .
  • Bijlsma JW, van der Goes MC, Hoes JN, Jacobs JW, Buttgereit F, Kirwan J . Low-dose glucocorticoid therapy in rheumatoid arthritis: an obligatory therapy . Ann N Y Acad Sci 2010;1193:123-6 .
  • Gorter SL, Bijlsma JW, Cutolo M, Gomez-Reino J, Kouloumas M, Smolen JS, et al . Current evidence for the management of rheumatoid arthritis with glucocorticoids: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis . Ann Rheum Dis 2010;69:1010-4 .
  • Mouterde G, Dernis E, Ruyssen-Witrand A, Claudepierre P, Schaeverbeke T, Cantagrel A, et al . Indications of glucocorticoids in early arthritis and rheumatoid arthritis: recommendations for clinical practice based on data from the literature and expert opinion . Joint Bone Spine 2010;77:597-603 .
  • National Collaborating Centre for Chronic Conditions (UK) . Rheumatoid Arthritis: National Clinical Guideline for Management and Treatment in Adults . London: Royal College of Physicians (UK); 2009 Feb:135-141 .National Institute for Health and Clinical Excellence: Guidance .
  • Hoes JN, Jacobs JW, Verstappen SM, Bijlsma JW, Van der Heijden GJ . Adverse events of low- to medium-dose oral glucocorticoids in inflammatory diseases: a meta- analysis . Ann Rheum Dis 2009 ;68:1833-8 .
  • Haraoui B, Pope J . Treatment of early rheumatoid arthritis: concepts in management . Semin Arthritis Rheum 2011;40:371-88 .
  • van Leeuwen MA, van Rijswijk MH, van der Heijde DM, Te Meerman GJ, van Riel PL, Houtman PM, et al . The acute-phase response in relation to radiographic progression in early rheumatoid arthritis: a prospective study during the first three years of the disease . Br J Rheumatol 1993;32 Suppl 3:9-13 .
  • Vastesaeger N, Xu S, Aletaha D, St Clair EW, Smolen JS . A pilot risk model for the prediction of rapid radiographic progression in rheumatoid arthritis . Rheumatology (Oxford) 2009;48:1114-21 .
  • Westhovens R, Robles M, Ximenes AC, Nayiager S, Wollenhaupt J, Durez P, et al . Clinical efficacy and safety of abatacept in methotrexate-naive patients with early rheumatoid arthritis and poor prognostic factors . Ann Rheum Dis 2009;68:1870-7 .
  • Bathon JM, Martin RW, Fleischmann RM, Tesser JR, Schiff MH, Keystone EC, et al . A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis . N Engl J Med 2000;343:1586-93 .
  • St Clair EW, van der Heijde DM, Smolen JS, Maini RN, Bathon JM, Emery P, et al . Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial . Arthritis Rheum 2004;50:3432-43 .
  • Breedveld FC, Weisman MH, Kavanaugh AF, Cohen SB, Pavelka K, van Vollenhoven R, et al . The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment . Arthritis Rheum 2006;54:26-37 .
  • Emery P, Genovese MC, van Vollenhoven R, Sharp JT, Patra K, Sasso EH . Less radiographic progression with adalimumab plus methotrexate versus methotrexate monotherapy across the spectrum of clinical response in early rheumatoid arthritis . J Rheumatol 2009;36:1429-41 .
  • Kuriya B, Arkema EV, Bykerk VP, Keystone EC . Efficacy of initial methotrexate monotherapy versus combination therapy with a biological agent in early rheumatoid arthritis: a meta-analysis of clinical and radiographic remission . Ann Rheum Dis 2010;69:1298-304 .
  • Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Allaart CF, van Zeben D, Kerstens PJ, Hazes JM, et al . Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial . Arthritis Rheum 2005 ;52:3381-90 .
  • Carswell EA, Old LJ, Kassel RL, Green S, Fiore N, Williamson B . An endotoxin-induced serum factor that causes necrosis of tumors . Proc Natl Acad Sci U S A
  • Maini RN, Breedveld FC, Kalden JR, Smolen JS, Davis D, Macfarlane JD, et al . Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis . Arthritis Rheum 1998 ;41:1552-63 .
  • Moreland LW, Schiff MH, Baumgartner SW, Tindall EA, Fleischmann RM, Bulpitt KJ, et al . Etanercept therapy in rheumatoid arthritis . A randomized, controlled trial . Ann Intern Med 1999;130:478-86 .
  • Weinblatt ME, Kremer JM, Bankhurst AD, Bulpitt KJ, Fleischmann RM, Fox RI, et al . A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate . N Engl J Med 1999;340:253-9 .
  • Klareskog L, van der Heijde D, de Jager JP, Gough A, Kalden J, Malaise M, et al . Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial . Lancet 2004;363:675-81 .
  • Weinblatt ME, Keystone EC, Furst DE, Moreland LW, Weisman MH, Birbara CA, et al . Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial . Arthritis Rheum 2003;48:35-45 .
  • Mpofu S, Fatima F, Moots RJ . Anti-TNF-alpha therapies: they are all the same (aren't they?) . Rheumatology (Oxford) 2005;44:271-3 .
  • Lutt JR, Deodhar A . Rheumatoid arthritis: strategies in the management of patients showing an inadequate response to TNFalpha antagonists . Drugs 2008;68:591- 606 .
  • Virkki LM, Valleala H, Takakubo Y, Vuotila J, Relas H, Komulainen R, et al . Outcomes of switching anti-TNF drugs in rheumatoid arthritis-a study based on observational data from the Finnish Register of Biological Treatment (ROB-FIN) . Clin Rheumatol 2011;30:1447-54 .
  • Scrivo R, Conti F, Spinelli FR, Truglia S, Magrini L, Di Franco M, et al . Switching between TNFalpha antagonists in rheumatoid arthritis: personal experience and review of the literature . Reumatismo 2009;61:107-17 .
  • Karlsson JA, Kristensen LE, Kapetanovic MC, Gülfe A, Saxne T, Geborek P . Treatment response to a second or third TNF-inhibitor in RA: results from the South Swedish Arthritis Treatment Group Register . Rheumatology (Oxford) 2008;47:507-13 .
  • Hyrich KL, Lunt M, Watson KD, Symmons DP, Silman AJ; British Society for Rheumatology Biologics Register . Outcomes after switching from one anti-tumor necrosis factor alpha agent to a second anti-tumor necrosis factor alpha agent in patients with rheumatoid arthritis: results from a large UK national cohort study . Arthritis Rheum 2007;56:13-20 .
  • Bartelds GM, Wijbrandts CA, Nurmohamed MT, Stapel S, Lems WF, Aarden L, et al . Anti-infliximab and anti-adalimumab antibodies in relation to response to adalimumab in infliximab switchers and anti-tumour necrosis factor naive patients: a cohort study . Ann Rheum Dis 2010;69:817-21 .
  • Hjardem E, Østergaard M, Pİdenphant J, Tarp U, Andersen LS, Bing J, et al . Do rheumatoid arthritis patients in clinical practice benefit from switching from infliximab to a second tumor necrosis factor alpha inhibitor? Ann Rheum Dis 2007;66:1184-9 .
  • Lee YH, Bae SC, Song GG . The efficacy and safety of rituximab for the treatment of active rheumatoid arthritis: a systematic review and meta-analysis of randomized controlled trials . Rheumatol Int 2011;31:1493-9 .
  • Buch MH, Smolen JS, Betteridge N, Breedveld FC, Burmester G, Dörner T, et al . Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis . Ann Rheum Dis 2011;70:909-20 .
  • Schiff M, Bessette L . Evaluation of abatacept in biologic- naïve patients with active rheumatoid arthritis . Clin Rheumatol 2010;29:583-91 .
  • Kawashiri SY, Kawakami A, Iwamoto N, Fujikawa K, Aramaki T, Tamai M, et al . Switching to the anti-interleukin-6 receptor antibody tocilizumab in rheumatoid arthritis patients refractory to antitumor necrosis factor biologics . Mod Rheumatol 2010;20:40-5 .
  • Nakashima Y, Kondo M, Harada H, Horiuchi T, Ishinishi T, Jojima H, et al . Clinical evaluation of tocilizumab for patients with active rheumatoid arthritis refractory to anti-TNF biologics: tocilizumab in combination with methotrexate . Mod Rheumatol 2010;20:343-52 .
  • Singh JA, Beg S, Lopez-Olivo MA . Tocilizumab for rheumatoid arthritis: a Cochrane systematic review . J Rheumatol 2011;38:10-20 .
  • Lie E, van der Heijde D, Uhlig T, Mikkelsen K, Kalstad S, Kaufmann C, et al . Treatment strategies in patients with rheumatoid arthritis for whom methotrexate monotherapy has failed: data from the NOR-DMARD register . Ann Rheum Dis 2011;70:2103-10 .
  • Wakabayashi H, Oka H, Nishioka Y, Hasegawa M, Sudo A, Nishioka K . Do biologics-naïve patients with rheumatoid arthritis respond better to tocilizumab than patients for whom anti-TNF agents have failed? A retrospective study . Clin Exp Rheumatol 2011;29:314-7 .
  • Yocum D . Immunological actions of cyclosporin A in rheumatoid arthritis . Br J Rheumatol 1993;32 Suppl 1:38-41 .
  • Kitahara K, Kawai S . Cyclosporine and tacrolimus for the treatment of rheumatoid arthritis . Curr Opin Rheumatol 2007;19:238-45 .
  • Tugwell P, Pincus T, Yocum D, Stein M, Gluck O, Kraag G, et al . Combination therapy with cyclosporine and methotrexate in severe rheumatoid arthritis . The Methotrexate-Cyclosporine Combination Study Group . N Engl J Med 1995;333:137-41 .
  • Díaz-Borjón A . Guidelines for the use of conventional and newer disease-modifying antirheumatic drugs in elderly patients with rheumatoid arthritis . Drugs Aging
  • American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines . Guidelines for the management of rheumatoid arthritis: 2002 Update . Arthritis Rheum 2002;46:328-46 .
  • Fİrre O . Radiologic evidence of disease modification in rheumatoid arthritis patients treated with cyclosporine . Results of a 48-week multicenter study comparing low- dose cyclosporine with placebo . Norwegian Arthritis Study Group . Arthritis Rheum 1994;37:1506-12 .
  • Gerards AH, Landewé RB, Prins AP, Bruyn GA, Goei Thé HS, Laan RF, et al . Cyclosporin A monotherapy versus cyclosporin A and methotrexate combination therapy in patients with early rheumatoid arthritis: a double blind randomised placebo controlled trial . Ann Rheum Dis 2003;62:291-6 .
  • Sarzi-Puttini P, D'Ingianna E, Fumagalli M, Scarpellini M, Fiorini T, Chérié-Lignière EL, et al . An open, randomized comparison study of cyclosporine A, cyclosporine A + methotrexate and cyclosporine A + hydroxychloroquine in the treatment of early severe rheumatoid arthritis . Rheumatol Int 2005;25:15-22 .
  • Shah F, Ali A, Mahmood K . Effectiveness and safety profile of cyclosporine a in rheumatoid arthritis . JPMI 2010;24:259-64 .
  • Wells G, Haguenauer D, Shea B, Suarez-Almazor ME, Welch VA, Tugwell P . Cyclosporine for rheumatoid arthritis . Cochrane Database Syst Rev 2000;CD001083 .
  • Heurkens AH, Westedt ML, Breedveld FC . Prednisone plus azathioprine treatment in patients with rheumatoid arthritis complicated by vasculitis . Arch Intern Med 1991;151:2249-54 .
  • Suarez-Almazor ME, Spooner C, Belseck E . Azathioprine for treating rheumatoid arthritis . Cochrane Database Syst Rev 2000;CD001461 .
  • Suarez-Almazor ME, Belseck E, Shea B, Wells G, Tugwell P . Cyclophosphamide for treating rheumatoid arthritis . Cochrane Database Syst Rev 2000;CD001157 .
  • Fautrel B, Guillemin F, Meyer O, de Bandt M, Berthelot JM, Flipo RM, et al . Choice of second- line disease-modifying antirheumatic drugs after failure of methotrexate therapy for rheumatoid arthritis: a decision tree for clinical practice based on rheumatologists' preferences . Arthritis Rheum 2009;61:425-34 .
  • Nam JL, Winthrop KL, van Vollenhoven RF, Pavelka K, Valesini G, Hensor EM, et al . Current evidence for the management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of RA . Ann Rheum Dis 2010;69:976-86 .
  • Kauppi MJ, Neva MH, Laiho K, Kautiainen H, Luukkainen R, Karjalainen A, et al . Rheumatoid atlantoaxial subluxation can be prevented by intensive use of traditional disease modifying antirheumatic drugs . J Rheumatol 2009;36:273-8 .
  • Smolen JS, Aletaha D . Developments in the clinical understanding of rheumatoid arthritis . Arthritis Res Ther 2009;11:204 .
  • Landewé RB, Boers M, Verhoeven AC, Westhovens R, van de Laar MA, Markusse HM, et al . COBRA combination therapy in patients with early rheumatoid arthritis: long- term structural benefits of a brief intervention . Arthritis
  • Wassenberg S, Rau R, Steinfeld P, Zeidler H . Very low- dose prednisolone in early rheumatoid arthritis retards radiographic progression over two years: a multicenter, double-blind, placebo-controlled trial . Arthritis Rheum 2005;52:3371-80 .
  • Möttönen TT, Hannonen PJ, Boers M . Combination DMARD therapy including corticosteroids in early rheumatoid arthritis . Clin Exp Rheumatol 1999;17:S59-65 .
  • Kirwan JR, Bijlsma JW, Boers M, Shea BJ . Effects of glucocorticoids on radiological progression in rheumatoid arthritis . Cochrane Database Syst Rev 2007;CD006356 .
  • Choy EH, Smith CM, Farewell V, Walker D, Hassell A, Chau L, et al . Factorial randomised controlled trial of glucocorticoids and combination disease modifying drugs in early rheumatoid arthritis . Ann Rheum Dis 2008;67:656-63 .
  • O'Dell JR, Leff R, Paulsen G, Haire C, Mallek J, Eckhoff PJ, et al . Treatment of rheumatoid arthritis with methotrexate and hydroxychloroquine, methotrexate and sulfasalazine, or a combination of the three medications: results of a two-year, randomized, double- blind, placebo-controlled trial . Arthritis Rheum 2002;46:1164-70 .
  • Saleem B, Brown AK, Keen H, Nizam S, Freeston J, Karim Z, et al . Disease remission state in patients treated with the combination of tumor necrosis factor blockade and methotrexate or with disease-modifying antirheumatic drugs: A clinical and imaging comparative study . Arthritis Rheum 2009;60:1915-22 .
  • Nurmohamed MT, Dijkmans BA . Are biologics more effective than classical disease-modifying antirheumatic drugs? Arthritis Res Ther 2008;10:118 .
  • Valesini G, Di Franco M, Spinelli FR, Scrivo R . Induction of remission in rheumatoid arthritis: criteria and opportunities . Rheumatol Int 2008 ;29:131-9 .
  • van der Kooij SM, de Vries-Bouwstra JK, Goekoop- Ruiterman YP, van Zeben D, Kerstens PJ, Gerards AH, et al . Limited efficacy of conventional DMARDs after initial methotrexate failure in patients with recent onset rheumatoid arthritis treated according to the disease activity score . Ann Rheum Dis 2007;66:1356-62 .
  • Knevel R, Schoels M, Huizinga TW, Aletaha D, Burmester GR, Combe B, et al . Current evidence for a strategic approach to the management of rheumatoid arthritis with disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis . Ann Rheum Dis 2010;69:987-94 .
  • Rantalaiho V, Korpela M, Hannonen P, Kautiainen H, Järvenpää S, Leirisalo-Repo M, et al . The good initial response to therapy with a combination of traditional disease-modifying antirheumatic drugs is sustained over time: the eleven-year results of the Finnish rheumatoid arthritis combination therapy trial . Arthritis Rheum 2009;60:1222-31 .
  • Ferraccioli GF, Casatta L, Di Poi E, Damato R, Bartoli E . Combination DMARD therapy for rheumatoid arthritis . Full or low DMARD doses? Ann Rheum Dis 1997;56:336-7 .
  • Verschueren P, Esselens G, Westhovens R . Daily practice effectiveness of a step-down treatment in comparison with a tight step-up for early rheumatoid arthritis . Rheumatology (Oxford) 2008;47:59-64 .
  • Donahue KE, Gartlehner G, Jonas DE, Lux LJ, Thieda P, Jonas BL, et al . Systematic review: comparative effectiveness and harms of disease-modifying medications for rheumatoid arthritis . Ann Intern Med 2008;148:124-34 .
  • Gorter SL, Bijlsma JW, Cutolo M, Gomez-Reino J, Kouloumas M, Smolen JS, et al . Current evidence for the management of rheumatoid arthritis with glucocorticoids: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis . Ann Rheum Dis 2010;69:1010-4 .
  • O'Mahony R, Richards A, Deighton C, Scott D . Withdrawal of disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: a systematic review and meta-analysis . Ann Rheum Dis 2010;69:1823-6 .
  • Klarenbeek NB, van der Kooij SM, Güler-Yüksel M, van Groenendael JH, Han KH, Kerstens PJ, et al . Discontinuing treatment in patients with rheumatoid arthritis in sustained clinical remission: exploratory analyses from the BeSt study . Ann Rheum Dis 2011;70:315-9 .
  • Klarenbeek NB, Güler-Yüksel M, van der Kooij SM, Han KH, Ronday HK, Kerstens PJ, et al . The impact of four dynamic, goal-steered treatment strategies on the 5-year outcomes of rheumatoid arthritis patients in the BeSt study . Ann Rheum Dis 2011;70:1039-46 .
  • van den Broek M, Klarenbeek NB, Dirven L, van Schaardenburg D, Hulsmans HM, Kerstens PJ, et al . Discontinuation of infliximab and potential predictors of persistent low disease activity in patients with early rheumatoid arthritis and disease activity score-steered therapy: subanalysis of the BeSt study . Ann Rheum Dis 2011;70:1389-94 .
  • van der Woude D, Young A, Jayakumar K, Mertens BJ, Toes RE, van der Heijde D, et al . Prevalence of and predictive factors for sustained disease-modifying antirheumatic drug-free remission in rheumatoid arthritis: results from two large early arthritis cohorts . Arthritis Rheum 2009 ;60:2262-71 .
  • Edworthy SM . How important is patient self- management? Baillieres Best Pract Res Clin Rheumatol 2000;14:705-14 .
  • Iversen MD, Hammond A, Betteridge N . Self- management of rheumatic diseases: state of the art and future perspectives . Ann Rheum Dis 2010;69:955-63 .
  • Martin RW, Brower ME, Geralds A, Gallagher PJ, Tellinghuisen DJ . An experimental evaluation of patient decision aid design to communicate the effects of medications on the rate of progression of structural joint damage in rheumatoid arthritis . Patient Educ Couns 2011 . [Epub ahead of print]
  • Schoels M, Aletaha D, Smolen JS, Bijlsma JW, Burmester G, Breedveld FC, et al . Follow-up standards and treatment targets in rheumatoid arthritis: results of a questionnaire at the EULAR 2008 . Ann Rheum Dis 2010;69:575-8 .
  • Salliot C, van der Heijde D . Long-term safety of methotrexate monotherapy in patients with rheumatoid arthritis: a systematic literature research . Ann Rheum Dis 2009;68:1100-4 .
  • Singh JA, Wells GA, Christensen R, Tanjong Ghogomu E, Maxwell L, Macdonald JK, et al . Adverse effects of biologics: a network meta-analysis and Cochrane overview . Cochrane Database Syst Rev 2011;CD008794 .
  • Zink A, Askling J, Dixon WG, Klareskog L, Silman AJ, Symmons DP . European biologicals registers: methodology, selected results and perspectives . Ann Rheum Dis 2009;68:1240-6 .
  • Gaujoux-Viala C, Smolen JS, Landewé R,
  • Dougados M, Kvien TK, Mola EM, et al . Current evidence for the management of rheumatoid arthritis with synthetic disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis . Ann Rheum Dis 2010;69:1004-9 .
  • Syversen SW, Gaarder PI, Goll GL, Ødegård S, Haavardsholm EA, Mowinckel P, et al . High anti- cyclic citrullinated peptide levels and an algorithm of four variables predict radiographic progression in patients with rheumatoid arthritis: results from a 10-year longitudinal study . Ann Rheum Dis 2008;67:212-7 .
  • Combe B, Landewe R, Lukas C, Bolosiu HD, Breedveld F, Dougados M, et al . EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT) . Ann Rheum Dis 2007;66:34-45 .
  • Mok CC, Tam LS, Chan TH, Lee GK, Li EK; Hong Kong Society of Rheumatology . Management of rheumatoid arthritis: consensus recommendations from the Hong Kong Society of Rheumatology . Clin Rheumatol
  • Dernis E, Ruyssen-Witrand A, Mouterde G,
  • Maillefert JF, Tebib J, Cantagrel A, et al . Use of glucocorticoids in rheumatoid arthritis - pratical modalities of glucocorticoid therapy: recommendations for clinical practice based on data from the literature and expert opinion . Joint Bone Spine 2010;77:451-7 .
  • Wallen M, Gillies D . Intra-articular steroids and splints/ rest for children with juvenile idiopathic arthritis and adults with rheumatoid arthritis . Cochrane Database Syst Rev 2006;CD002824 .
  • Blyth T, Hunter JA, Stirling A . Pain relief in the rheumatoid knee after steroid injection . A single- blind comparison of hydrocortisone succinate, and triamcinolone acetonide or hexacetonide . Br J Rheumatol 1994 ;33:461-3 .
  • Habib GS . Systemic effects of intra-articular corticosteroids . Clin Rheumatol 2009;28:749-56 .
  • Hurkmans EJ, Jones A, Li LC, Vliet Vlieland TP . Quality appraisal of clinical practice guidelines on the use of physiotherapy in rheumatoid arthritis: a systematic review . Rheumatology (Oxford) 2011;50:1879-88 .
  • Vliet Vlieland TP, Pattison D . Non-drug therapies in early rheumatoid arthritis . Best Pract Res Clin Rheumatol 2009;23:103-16 .
  • Forestier R, André-Vert J, Guillez P, Coudeyre E, Lefevre-Colau MM, Combe B, et al . Non-drug treatment (excluding surgery) in rheumatoid arthritis: clinical practice guidelines . Joint Bone Spine 2009;76:691-8 .
  • Gossec L, Pavy S, Pham T, Constantin A, Poiraudeau S, Combe B, et al . Nonpharmacological treatments in early rheumatoid arthritis: clinical practice guidelines based on published evidence and expert opinion . Joint Bone Spine 2006;73:396-402 .
  • Luqmani R, Hennell S, Estrach C, Birrell F, Bosworth A, Davenport G, et al . British Society for Rheumatology and british health professionals in Rheumatology guideline for the management of rheumatoid arthritis (the first two years) . Rheumatology (Oxford) 2006;45:1167-9 .
  • Hennell S, Luqmani R . Developing multidisciplinary guidelines for the management of early rheumatoid arthritis . Musculoskeletal Care 2008;6:97-107 .
  • Vliet Vlieland TP . Non-drug care for RA-is the era of evidence-based practice approaching? Rheumatology (Oxford) 2007;46:1397-404 .
  • Van Den Ende CH, Vliet Vlieland TP, Munneke M, Hazes JM . Dynamic exercise therapy for rheumatoid arthritis . Cochrane Database Syst Rev 2000;CD000322 .
  • Stenström CH, Minor MA . Evidence for the benefit of aerobic and strengthening exercise in rheumatoid arthritis . Arthritis Rheum 2003;49:428-34 .
  • de Jong Z, Munneke M, Zwinderman AH, Kroon HM, Jansen A, Ronday KH, et al . Is a long- term high-intensity exercise program effective and safe in patients with rheumatoid arthritis? Results of a randomized controlled trial . Arthritis Rheum 2003;48:2415-24 .
  • Munneke M, de Jong Z, Zwinderman AH, Ronday HK, van Schaardenburg D, Dijkmans BA, et al . Effect of a high-intensity weight-bearing exercise program on radiologic damage progression of the large joints in subgroups of patients with rheumatoid arthritis . Arthritis Rheum 2005;53:410-7 .
  • Häkkinen A, Sokka T, Hannonen P . A home-based two-year strength training period in early rheumatoid arthritis led to good long-term compliance: a five-year followup . Arthritis Rheum 2004;51:56-62 .
  • Hurkmans E, van der Giesen FJ, Vliet Vlieland TP, Schoones J, Van den Ende EC . Dynamic exercise programs (aerobic capacity and/or muscle strength training) in patients with rheumatoid arthritis . Cochrane Database Syst Rev 2009;CD006853 .
  • Egan M, Brosseau L, Farmer M, Ouimet MA, Rees S, Wells G, et al . Splints/orthoses in the treatment of rheumatoid arthritis . Cochrane Database Syst Rev 2003;CD004018 .
  • Hammond A . Rehabilitation in musculoskeletal diseases . Best Pract Res Clin Rheumatol 2008;22:435- 49 .
  • Veehof MM, Taal E, Heijnsdijk-Rouwenhorst LM, van de Laar MA . Efficacy of wrist working splints in patients with rheumatoid arthritis: a randomized controlled study . Arthritis Rheum 2008;59:1698-704 .
  • Silva AC, Jones A, Silva PG, Natour J . Effectiveness of a night-time hand positioning splint in rheumatoid arthritis: a randomized controlled trial . J Rehabil Med 2008;40:749-54 .
  • Zijlstra TR, Heijnsdijk-Rouwenhorst L, Rasker JJ . Silver ring splints improve dexterity in patients with rheumatoid arthritis . Arthritis Rheum 2004;51:947-51 .
  • van der Giesen FJ, van Lankveld WJ, Kremers-Selten C, Peeters AJ, Stern EB, Le Cessie S, et al . Effectiveness of two finger splints for swan neck deformity in patients with rheumatoid arthritis: a randomized, crossover trial . Arthritis Rheum 2009;61:1025-31 .
  • Pagnotta A, Baron M, Korner-Bitensky N . The effect of a static wrist orthosis on hand function in individuals with rheumatoid arthritis . J Rheumatol 1998;25:879-85 .
  • Adams J, Burridge J, Mullee M, Hammond A, Cooper C . The clinical effectiveness of static resting splints in early rheumatoid arthritis: a randomized controlled trial . Rheumatology (Oxford) 2008;47:1548-53 .
  • Christie A, Jamtvedt G, Dahm KT, Moe RH, Haavardsholm EA, Hagen KB . Effectiveness of nonpharmacological and nonsurgical interventions for patients with rheumatoid arthritis: an overview of systematic reviews . Phys Ther 2007;87:1697-715 .
  • Hawke F, Burns J, Radford JA, du Toit V . Custom-made foot orthoses for the treatment of foot pain . Cochrane Database Syst Rev 2008; CD006801 .
  • Verhagen AP, Bierma-Zeinstra SM, Cardoso JR, de Bie RA, Boers M, de Vet HC . Balneotherapy for rheumatoid arthritis . Cochrane Database Syst Rev 2003;CD000518 .
  • Ottawa Panel . Ottawa Panel Evidence-Based Clinical Practice Guidelines for Electrotherapy and Thermotherapy Interventions in the Management of Rheumatoid Arthritis in Adults . Phys Ther 2004;84:1016-43 .
APA ATAMAN Ş, BORMAN P, Evcik F, AYDOĞ E, Ayhan F, YILDIZLAR D, BODUR H, ALTAY Z, BİRTANE M, BÜTÜN B, DURUÖZ M, Erdem H, günendi z, GUNAYDIN R, gurer g, KAÇAR C, KAPTANOĞLU E, Kaya T, ÖLMEZ N, Paker N, rezvani a, SONEL TUR B, YENER M, ÖZGÖÇMEN S (2011). Management of Rheumatoid Arthritis: Consensus Recommendations From the Turkish League Against Rheumatism. , 273 - 294.
Chicago ATAMAN Şebnem,BORMAN Pınar,Evcik Fatma Deniz,AYDOĞ Ece,Ayhan Fikriye Figen,YILDIZLAR Derya,BODUR Hatice,ALTAY ZUHAL,BİRTANE Murat,BÜTÜN Bülent,DURUÖZ Mehmet Tuncay,Erdem Hatice Rana,günendi zafer,GUNAYDIN Rezzan,gurer gülcan,KAÇAR Cahit,KAPTANOĞLU Ece,Kaya Taciser,ÖLMEZ Neşe,Paker Nurdan,rezvani aylin,SONEL TUR BİRKAN,YENER Mahmut,ÖZGÖÇMEN Salih Management of Rheumatoid Arthritis: Consensus Recommendations From the Turkish League Against Rheumatism. (2011): 273 - 294.
MLA ATAMAN Şebnem,BORMAN Pınar,Evcik Fatma Deniz,AYDOĞ Ece,Ayhan Fikriye Figen,YILDIZLAR Derya,BODUR Hatice,ALTAY ZUHAL,BİRTANE Murat,BÜTÜN Bülent,DURUÖZ Mehmet Tuncay,Erdem Hatice Rana,günendi zafer,GUNAYDIN Rezzan,gurer gülcan,KAÇAR Cahit,KAPTANOĞLU Ece,Kaya Taciser,ÖLMEZ Neşe,Paker Nurdan,rezvani aylin,SONEL TUR BİRKAN,YENER Mahmut,ÖZGÖÇMEN Salih Management of Rheumatoid Arthritis: Consensus Recommendations From the Turkish League Against Rheumatism. , 2011, ss.273 - 294.
AMA ATAMAN Ş,BORMAN P,Evcik F,AYDOĞ E,Ayhan F,YILDIZLAR D,BODUR H,ALTAY Z,BİRTANE M,BÜTÜN B,DURUÖZ M,Erdem H,günendi z,GUNAYDIN R,gurer g,KAÇAR C,KAPTANOĞLU E,Kaya T,ÖLMEZ N,Paker N,rezvani a,SONEL TUR B,YENER M,ÖZGÖÇMEN S Management of Rheumatoid Arthritis: Consensus Recommendations From the Turkish League Against Rheumatism. . 2011; 273 - 294.
Vancouver ATAMAN Ş,BORMAN P,Evcik F,AYDOĞ E,Ayhan F,YILDIZLAR D,BODUR H,ALTAY Z,BİRTANE M,BÜTÜN B,DURUÖZ M,Erdem H,günendi z,GUNAYDIN R,gurer g,KAÇAR C,KAPTANOĞLU E,Kaya T,ÖLMEZ N,Paker N,rezvani a,SONEL TUR B,YENER M,ÖZGÖÇMEN S Management of Rheumatoid Arthritis: Consensus Recommendations From the Turkish League Against Rheumatism. . 2011; 273 - 294.
IEEE ATAMAN Ş,BORMAN P,Evcik F,AYDOĞ E,Ayhan F,YILDIZLAR D,BODUR H,ALTAY Z,BİRTANE M,BÜTÜN B,DURUÖZ M,Erdem H,günendi z,GUNAYDIN R,gurer g,KAÇAR C,KAPTANOĞLU E,Kaya T,ÖLMEZ N,Paker N,rezvani a,SONEL TUR B,YENER M,ÖZGÖÇMEN S "Management of Rheumatoid Arthritis: Consensus Recommendations From the Turkish League Against Rheumatism." , ss.273 - 294, 2011.
ISNAD ATAMAN, Şebnem vd. "Management of Rheumatoid Arthritis: Consensus Recommendations From the Turkish League Against Rheumatism". (2011), 273-294.
APA ATAMAN Ş, BORMAN P, Evcik F, AYDOĞ E, Ayhan F, YILDIZLAR D, BODUR H, ALTAY Z, BİRTANE M, BÜTÜN B, DURUÖZ M, Erdem H, günendi z, GUNAYDIN R, gurer g, KAÇAR C, KAPTANOĞLU E, Kaya T, ÖLMEZ N, Paker N, rezvani a, SONEL TUR B, YENER M, ÖZGÖÇMEN S (2011). Management of Rheumatoid Arthritis: Consensus Recommendations From the Turkish League Against Rheumatism. Turkish Journal of Rheumatology(.)Archives of Rheumatology, 26(4), 273 - 294.
Chicago ATAMAN Şebnem,BORMAN Pınar,Evcik Fatma Deniz,AYDOĞ Ece,Ayhan Fikriye Figen,YILDIZLAR Derya,BODUR Hatice,ALTAY ZUHAL,BİRTANE Murat,BÜTÜN Bülent,DURUÖZ Mehmet Tuncay,Erdem Hatice Rana,günendi zafer,GUNAYDIN Rezzan,gurer gülcan,KAÇAR Cahit,KAPTANOĞLU Ece,Kaya Taciser,ÖLMEZ Neşe,Paker Nurdan,rezvani aylin,SONEL TUR BİRKAN,YENER Mahmut,ÖZGÖÇMEN Salih Management of Rheumatoid Arthritis: Consensus Recommendations From the Turkish League Against Rheumatism. Turkish Journal of Rheumatology(.)Archives of Rheumatology 26, no.4 (2011): 273 - 294.
MLA ATAMAN Şebnem,BORMAN Pınar,Evcik Fatma Deniz,AYDOĞ Ece,Ayhan Fikriye Figen,YILDIZLAR Derya,BODUR Hatice,ALTAY ZUHAL,BİRTANE Murat,BÜTÜN Bülent,DURUÖZ Mehmet Tuncay,Erdem Hatice Rana,günendi zafer,GUNAYDIN Rezzan,gurer gülcan,KAÇAR Cahit,KAPTANOĞLU Ece,Kaya Taciser,ÖLMEZ Neşe,Paker Nurdan,rezvani aylin,SONEL TUR BİRKAN,YENER Mahmut,ÖZGÖÇMEN Salih Management of Rheumatoid Arthritis: Consensus Recommendations From the Turkish League Against Rheumatism. Turkish Journal of Rheumatology(.)Archives of Rheumatology, vol.26, no.4, 2011, ss.273 - 294.
AMA ATAMAN Ş,BORMAN P,Evcik F,AYDOĞ E,Ayhan F,YILDIZLAR D,BODUR H,ALTAY Z,BİRTANE M,BÜTÜN B,DURUÖZ M,Erdem H,günendi z,GUNAYDIN R,gurer g,KAÇAR C,KAPTANOĞLU E,Kaya T,ÖLMEZ N,Paker N,rezvani a,SONEL TUR B,YENER M,ÖZGÖÇMEN S Management of Rheumatoid Arthritis: Consensus Recommendations From the Turkish League Against Rheumatism. Turkish Journal of Rheumatology(.)Archives of Rheumatology. 2011; 26(4): 273 - 294.
Vancouver ATAMAN Ş,BORMAN P,Evcik F,AYDOĞ E,Ayhan F,YILDIZLAR D,BODUR H,ALTAY Z,BİRTANE M,BÜTÜN B,DURUÖZ M,Erdem H,günendi z,GUNAYDIN R,gurer g,KAÇAR C,KAPTANOĞLU E,Kaya T,ÖLMEZ N,Paker N,rezvani a,SONEL TUR B,YENER M,ÖZGÖÇMEN S Management of Rheumatoid Arthritis: Consensus Recommendations From the Turkish League Against Rheumatism. Turkish Journal of Rheumatology(.)Archives of Rheumatology. 2011; 26(4): 273 - 294.
IEEE ATAMAN Ş,BORMAN P,Evcik F,AYDOĞ E,Ayhan F,YILDIZLAR D,BODUR H,ALTAY Z,BİRTANE M,BÜTÜN B,DURUÖZ M,Erdem H,günendi z,GUNAYDIN R,gurer g,KAÇAR C,KAPTANOĞLU E,Kaya T,ÖLMEZ N,Paker N,rezvani a,SONEL TUR B,YENER M,ÖZGÖÇMEN S "Management of Rheumatoid Arthritis: Consensus Recommendations From the Turkish League Against Rheumatism." Turkish Journal of Rheumatology(.)Archives of Rheumatology, 26, ss.273 - 294, 2011.
ISNAD ATAMAN, Şebnem vd. "Management of Rheumatoid Arthritis: Consensus Recommendations From the Turkish League Against Rheumatism". Turkish Journal of Rheumatology(.)Archives of Rheumatology 26/4 (2011), 273-294.
Sayfa Oluşturulma Tarihi
22-04-2024 23:19

İLETİŞİM

TÜBİTAK ULAKBİM TR Dizin

Yüzüncüyıl, İşçi Blokları Mahallesi

Muhsin Yazıcıoğlu Caddesi No:51/C

06530 Çankaya / ANKARA +90 (312) 298 92 00

trdizin@tubitak.gov.tr

TÜBİTAK ULAKBİM Ulusal Akademik Ağ ve Bilgi Merkezi Cahit Arf Bilgi Merkezi © Tüm Hakları Saklıdır. Gizlilik Politikası Kullanım Şartları